Myopia Profile

MiYOSMART

The MiYOSMART spectacle lens can be considered as a first-line treatment for simultaneous myopic correction and myopia control, with a two-year randomized controlled trial showing robust efficacy and acceptance in children. Data for up to six years of wear in children has been published, as well as eight-year data. It can be considered as one of the best available myopia control spectacle lens designs, being superior to progressive addition and bifocal lenses.

Visit the MiYOSMART website.

Spectacle lenses
HOYA
MiYOSMART
Spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology
Central clear zone of 9.4mm with no defocus segments, for correcting distance refractive error and providing clear vision. Surrounding treatment zone of DIMS structure allows normal visual perception and myopia management simultaneously. The lens has myopic defocus segments distributed in a high-density honeycomb structure over a 33mm area. Each segment provides defocus of +3.5D. The ratio of defocus and focus areas within a pupil size is around 50:50 everywhere on the lens.
Plano to -13.00, cylindrical correction up to 4.00, prism up to 3 PD per lens
Polycarbonate 1.59. Also available in Polarised and Photochromic sun options.
Diameter (60⌀, 65⌀, 70⌀, 75⌀)
With full refraction, taking monocular pupillary distances and monocular heights.
Platinum Sponsor Spectacles

MiYOSMART Information

Product disclaimer

MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.

Articles on MiYOSMART.

Understanding the HOYA MiYOSMART spectacle lens performanceThe Hoya MiYOSMART was the first of the new generation of myopia control spectacle lenses. Learn more here.Read Full Article Sun protection and myopia management - Q&A with Dr May Zhang and Jeff BrownWe meet Dr May Zhang and Mr Jeff Brown of HOYA Vision Care about the importance of outdoor time and sun protection in children with myopia.Read Full Article Three key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read Full Article
Understanding the HOYA MiYOSMART spectacle lens performanceThe Hoya MiYOSMART was the first of the new generation of myopia control spectacle lenses. Learn more here.Read Full Article

HOYA resources

Summary of all MiYOSMART studies

Learn more about the MiYOSMART lens as an innovative and evidence-based option for myopia management, with links to the 2-year and 3-year published studies, as well as 6-year data and 8-year data. Further studies on adaptation, visual function, optics and even combination with atropine via this link.

Learn More about Summary of all MiYOSMART studies